November 7th 2024
Sheldon M. Feldman, MD, discusses the significance of the new classification of HER2-low breast cancer and how this affects HER2+ breast cancer treatment
October 29th 2024
Sheldon M. Feldman, MD, discusses how the use of personalized medicine has evolved in breast cancer management.
October 28th 2024
Sheldon M. Feldman, MD, discusses the importance of Breast Cancer Awareness Month as well as timely screening and early detection.
August 14th 2024
Sheldon Feldman, MD, discusses prevention and management strategies for breast cancer–related lymphedema.
July 20th 2024
Sheldon Feldman, MD discusses new approaches for decreasing the risk of and managing breast cancer¬–related lymphedema.